A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination
- PMID: 12388963
- DOI: 10.1067/mob.2002.127461
A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination
Abstract
Objective: Our purpose was to compare the efficacy of oral misoprostol with that of vaginal misoprostol for midtrimester termination of pregnancy.
Study design: Women seen for midtrimester pregnancy termination were randomly assigned to receive either misoprostol orally in a dose of 200 microg every hour for 3 hours followed by 400 microg every 4 hours or vaginally in a dose of 400 microg every 4 hours. The protocol was followed for 24 hours, after which time further management was at the discretion of the attending physician. The primary outcome measure was the induction-to-delivery interval. Sample size was calculated a priori. Statistical analysis was performed with the t test for continuous variables and the chi(2) test for categorical variables. P <.05 was considered significant.
Results: One hundred fourteen women were randomized, with 49 receiving vaginal misoprostol and 65 receiving oral misoprostol. The two groups were comparable with respect to maternal age, parity, indication for pregnancy termination, gestational age, and maternal weight. The mean induction-to-delivery interval was significantly shorter for the vaginal group (19.6 +/- 17.5 hours vs 34.5 +/- 28.2 hours, P <.01). Length of stay was also shorter in the vaginal group (32.3 +/- 17.3 hours vs 50.9 +/- 27.9 hours, P <.01). Significantly more patients in the vaginal group were delivered within 24 hours (85.1% vs 39.5%, P <.01), and more patients in the oral group required changes in the method of induction when they were undelivered after 24 hours (38.2% vs 7%, P <.01). The only complication was an increase in febrile morbidity in the vaginal group (25% vs 6.7%, P =.046). This did not result in an increased use of antibiotics, and all the fevers resolved post partum without further complications.
Conclusions: Vaginal administration of misoprostol resulted in a shorter induction-to-delivery interval. The shorter length of stay should result in improved patient care.
Similar articles
-
A randomized comparison of two regimens of misoprostol for second-trimester pregnancy termination.Am J Obstet Gynecol. 2003 Sep;189(3):710-3. doi: 10.1067/s0002-9378(03)00659-8. Am J Obstet Gynecol. 2003. PMID: 14526299 Clinical Trial.
-
The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination.Am J Obstet Gynecol. 2002 Mar;186(3):470-4. doi: 10.1067/mob.2002.121085. Am J Obstet Gynecol. 2002. PMID: 11904609 Clinical Trial.
-
Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial.Contraception. 1998 Oct;58(4):207-10. doi: 10.1016/s0010-7824(98)00099-7. Contraception. 1998. PMID: 9866000 Clinical Trial.
-
A comparison of oral misoprostol with vaginal misoprostol administration in second-trimester pregnancy termination for fetal abnormality.Obstet Gynecol. 2003 Jun;101(6):1294-9. doi: 10.1016/s0029-7844(03)00357-0. Obstet Gynecol. 2003. PMID: 12798539 Clinical Trial.
-
High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial.Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):1065-70. doi: 10.1016/j.ajog.2005.05.087. Am J Obstet Gynecol. 2005. PMID: 16157113 Free PMC article. Clinical Trial.
Cited by
-
Medical treatment for early fetal death (less than 24 weeks).Cochrane Database Syst Rev. 2019 Jun 17;6(6):CD002253. doi: 10.1002/14651858.CD002253.pub4. Cochrane Database Syst Rev. 2019. PMID: 31206170 Free PMC article.
-
Medical treatments for incomplete miscarriage (less than 24 weeks).Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007223. doi: 10.1002/14651858.CD007223.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007223. doi: 10.1002/14651858.CD007223.pub3. PMID: 20091626 Free PMC article. Updated.
-
Comparison of Vaginal and Oral Doses of Misoprostol for Labour Induction in Post-Term Pregnancies.J Clin Diagn Res. 2016 Mar;10(3):QC08-11. doi: 10.7860/JCDR/2016/17389.7402. Epub 2016 Mar 1. J Clin Diagn Res. 2016. PMID: 27134946 Free PMC article.
-
Methods for managing miscarriage: a network meta-analysis.Cochrane Database Syst Rev. 2021 Jun 1;6(6):CD012602. doi: 10.1002/14651858.CD012602.pub2. Cochrane Database Syst Rev. 2021. PMID: 34061352 Free PMC article.
-
Medical treatment for early fetal death (less than 24 weeks).Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD002253. doi: 10.1002/14651858.CD002253.pub3. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2019 Jun 17;6:CD002253. doi: 10.1002/14651858.CD002253.pub4. PMID: 16855990 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical